Flublok Quadrivalent FDA Approval History
FDA Approved: Yes (First approved October 7, 2016)
Brand name: Flublok Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Protein Sciences Corp.
Treatment for: Influenza Prophylaxis
Flublok Quadrivalent is an influenza virus vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .
Development Timeline for Flublok Quadrivalent
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.